Evidence map›Paper›PMID 33439403›Full record

ArticleInternational urology and nephrology2021

Gadolinium-based contrast media exposure and the possible risk of subclinical kidney damage: a pilot study.

Francesca Martino, Gianpaolo Amici, Ilaria Godi, Michele Baretta, Caterina Biasi, Mariarosa Carta, Valentina Corradi, Massimo De Cal, MaÍra Knust, Claudia Tamayod and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in International urology and nephrology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Francesca MartinoInternational Renal Research Institute Vicenza, Vicenza, Italy. francesca.martino.k@gmail.com.ORCID http://orcid.org/0000-0002-2402-9276
Gianpaolo AmiciUO Nephrology and Dialysis, San Daniele del Friuli, and Tolmezzo Hospital, ASUFC, San Daniele del Friuli, Italy.
Ilaria GodiInternational Renal Research Institute Vicenza, Vicenza, Italy.
Michele BarettaInternational Renal Research Institute Vicenza, Vicenza, Italy.
Caterina BiasiInternational Renal Research Institute Vicenza, Vicenza, Italy.
Mariarosa CartaDepartment of Laboratory Medicine, San Bortolo Hospital, Vicenza, Italy.
Valentina CorradiInternational Renal Research Institute Vicenza, Vicenza, Italy.
Massimo De CalInternational Renal Research Institute Vicenza, Vicenza, Italy.
MaÍra KnustInternational Renal Research Institute Vicenza, Vicenza, Italy.
Claudia TamayodInternational Renal Research Institute Vicenza, Vicenza, Italy.
Alessia VarottoDepartment of Neuroradiology, San Bortolo Hospital, Vicenza, Italy.
Giuseppe IannucciDepartment of Neuroradiology, San Bortolo Hospital, Vicenza, Italy.
Davide GiavarinaDepartment of Laboratory Medicine, San Bortolo Hospital, Vicenza, Italy.
Sergio SavastanoDepartment of Radiology, San Bortolo Hospital, Vicenza, Italy.
Claudio RoncoInternational Renal Research Institute Vicenza, Vicenza, Italy.
International Renal Research Institute of Vicenza · ITOspedale San Bortolo · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWe performed a pilot study to evaluate the feasibility of future research about the presence of subclinical kidney damage after Gadolinium-based contrast media exposure. The future study aims to understand which are the behaviors of two markers of kidney damage, such as urinary NephroCheck (NC) and/or neutrophil gelatinase-associated lipocalin (NGAL). Specifically, after GBCM exposure, NC urinary detection should identify proximal tubule damage while NGAL urinary detection should be related to distal tubule damage.

methodsWe performed a pilot study in patients who had Gadolinium exposure. The feasibility of future study is reached when at least 90% of candidates completed the pilot study. In each patient, we tested urinary NC and NGAL levels 24 h before magnetic resonance imaging (MRI) and 12-24 h after the exposure. Furthermore, we evaluated the administration of other nephrotoxic agents, the presence of comorbidity, and kidney function by S-creatinine and urine protein before the MRI.

resultsWe enrolled 35 candidates of whom 33 patients completed all study procedures. Our population had a mean age of 60.7 ± 14.8 years with normal kidney function with a median S-creatinine equal to 0.7 mg/dl (Interquartile range [IQR] 0.6-0.91). Urinary NC levels increased from 0.21 ng

conclusionOur pilot study seems adequate in terms of feasibility and encourages us to focus our future research on renal proximal tubule, as the principal site of subclinical kidney damage after Gadolinium exposure.

Indexed as

Magnetic Resonance ImagingAcute Kidney InjuryAgedBiomarkersBiomedical ResearchContrast MediaFeasibility StudiesFemaleGadoliniumHumansKidney Function TestsLipocalin-2MaleMiddle AgedPilot ProjectsRisk AssessmentBiomarkersContrast MediaGadoliniumLipocalin-2Adverse effectsGadolinium-based contrast mediaKidney tubules

Identifiers

PMID33439403
OpenAlexW3119817885

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.